
Alvotech and Dr. Reddy’s announce FDA acceptance of Biologic License Application for AVT03
“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.."